Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D N Rush

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
The New England Journal of Medicine|July 14, 2001
Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejectionP C Grimm, P Nickerson, J Jeffery, et al.
Journal of the American Society of Nephrology : JASN|July 15, 1999
Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophagesP C Grimm, R McKenna, P Nickerson, et al.
Clinical Transplants|January 1, 1988
Transplantation in ManitobaJ R Jeffery, A Downs, H Fong, et al.
Transplantation|February 7, 2001
Increased levels of GALbeta1-4GLCNACalpha2-6 sialyltransferase pretransplant predict delayed graft function in kidney transplant recipientsG Thorne-Tjomsland, T Hosfield, J C Jamieson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 21, 2012
Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplantC Wiebe, I W Gibson, T D Blydt-Hansen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 23, 2015
Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibodyC Wiebe, I W Gibson, T D Blydt-Hansen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 30, 2013
Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomesC Wiebe, D Pochinco, T D Blydt-Hansen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 20, 2016
Evaluation of C1q Status and Titer of De Novo Donor-Specific Antibodies as Predictors of Allograft SurvivalC Wiebe, A J Gareau, D Pochinco, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 26, 2007
Protocol biopsies in renal transplantation: insights into patient management and pathogenesisM Mengel, J R Chapman, F G Cosio, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The New England Journal of Medicine|July 14, 2001
Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejectionP C Grimm, P Nickerson, J Jeffery, et al.
Journal of the American Society of Nephrology : JASN|July 15, 1999
Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophagesP C Grimm, R McKenna, P Nickerson, et al.
Clinical Transplants|January 1, 1988
Transplantation in ManitobaJ R Jeffery, A Downs, H Fong, et al.
Transplantation|February 7, 2001
Increased levels of GALbeta1-4GLCNACalpha2-6 sialyltransferase pretransplant predict delayed graft function in kidney transplant recipientsG Thorne-Tjomsland, T Hosfield, J C Jamieson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 21, 2012
Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplantC Wiebe, I W Gibson, T D Blydt-Hansen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 23, 2015
Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibodyC Wiebe, I W Gibson, T D Blydt-Hansen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 30, 2013
Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomesC Wiebe, D Pochinco, T D Blydt-Hansen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 20, 2016
Evaluation of C1q Status and Titer of De Novo Donor-Specific Antibodies as Predictors of Allograft SurvivalC Wiebe, A J Gareau, D Pochinco, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 26, 2007
Protocol biopsies in renal transplantation: insights into patient management and pathogenesisM Mengel, J R Chapman, F G Cosio, et al.
Pageof 3